|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/48 | |||
| A61K 31/44 | |||
| A61P 9/04 | |||
| A61P 9/10 | |||
| A61P 9/12 |
| (11) | Number of the document | 1355632 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01995820.6 |
| Date of filing the European patent application | 2001-12-31 | |
| (97) | Date of publication of the European application | 2003-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2007-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NL2001/000947 |
| Date | 2001-12-31 |
| (87) | Number | WO 2002/053135 |
| Date | 2002-07-11 |
| (30) | Number | Date | Country code |
| 258613 P | 2000-12-29 | US | |
| 809351 | 2001-03-16 | US |
| (72) |
PETERS, Theodorus, Hendricus, Antonius, NL
BENNEKER, Franciscus, Bernardus, Gemma, NL
LEMMENS, Jacobus, Maria, NL
KELTJENS, Rolf, NL
|
| (73) |
Pfizer Limited,
261 Ramsgate Road, Sandwich, Kent CT13 9NJ,
GB
|
| (54) | AMLODIPINE FREE BASE |
| AMLODIPINE FREE BASE |